US Stock MarketDetailed Quotes
ACTU Actuate Therapeutics
- 8.980
- -0.020-0.22%
Close Nov 22 16:00 ET
- 8.980
- 0.0000.00%
Post 20:01 ET
175.39MMarket Cap-6163P/E (TTM)
9.000High8.750Low31.54KVolume8.922Open9.000Pre Close281.28KTurnover1.13%Turnover RatioLossP/E (Static)19.53MShares10.16252wk High32.77P/B25.14MFloat Cap5.51052wk Low--Dividend TTM2.80MShs Float10.162Historical High--Div YieldTTM2.78%Amplitude5.510Historical Low8.919Avg Price1Lot Size
Actuate Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | |||||||||
| Cash flow from continuing operating activities | -62.27%-9.15M | 47.74%-2.67M | 2.08%-5.25M | -21.53%-21.63M | -5.51M | -5.64M | -5.12M | -5.36M | -17.79M |
| Net income from continuing operations | 5.79%-5.97M | -18.97%-6.57M | -57.41%-8.3M | -22.74%-24.74M | ---7.61M | ---6.34M | ---5.52M | ---5.27M | ---20.16M |
| Operating gains losses | -3,085.05%-537.19K | 777.27%440.34K | 4,655.54%232.52K | 318.22%79.82K | --51.6K | ---16.87K | --50.19K | ---5.1K | ---36.58K |
| Other non cash items | -32.59%3.41K | 0.28%5.08K | -82.16%5.08K | 169.39%43.64K | --5.06K | --5.06K | --5.06K | --28.45K | --16.2K |
| Change In working capital | -891.51%-4.4M | 852.25%2.66M | 1,376.66%2.36M | 48.56%2.57M | --1.92M | --556.25K | --279.67K | ---185.07K | --1.73M |
| -Change in prepaid assets | -37,520.15%-541.35K | ---78.2K | -1,679.92%-82.87K | 87.51%-3.16K | ---6.97K | ---1.44K | --0 | --5.25K | ---25.3K |
| -Change in payables and accrued expense | -792.39%-3.86M | 880.22%2.74M | 1,385.02%2.45M | 46.60%2.58M | --1.93M | --557.69K | --279.67K | ---190.31K | --1.76M |
| Cash from discontinued investing activities | |||||||||
| Operating cash flow | -62.27%-9.15M | 47.74%-2.67M | 2.08%-5.25M | -21.53%-21.63M | ---5.51M | ---5.64M | ---5.12M | ---5.36M | ---17.79M |
| Investing cash flow | |||||||||
| Cash flow from continuing investing activities | |||||||||
| Cash from discontinued investing activities | |||||||||
| Financing cash flow | |||||||||
| Cash flow from continuing financing activities | 22.32M | -42.73%957.04K | 76.88%4.36M | -78.53%4.13M | 0 | 0 | 1.67M | 2.46M | 19.26M |
| Net issuance payments of debt | --0 | --1M | --4.5M | ---- | ---- | --0 | --0 | --0 | ---- |
| Net preferred stock issuance | --0 | --0 | --0 | -78.53%4.13M | --0 | --0 | --1.67M | --2.46M | --19.26M |
| Net other financing activities | ---1.64M | ---42.96K | ---142.77K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | |||||||||
| Financing cash flow | --22.32M | -42.73%957.04K | 76.88%4.36M | -78.53%4.13M | --0 | --0 | --1.67M | --2.46M | --19.26M |
| Net cash flow | |||||||||
| Beginning cash position | -97.51%351.71K | -88.22%2.07M | -85.53%2.96M | 7.70%20.45M | --8.47M | --14.11M | --17.55M | --20.45M | --18.99M |
| Current changes in cash | 333.61%13.17M | 50.17%-1.72M | 69.25%-890.35K | -1,296.78%-17.49M | ---5.51M | ---5.64M | ---3.45M | ---2.9M | --1.46M |
| End cash Position | 59.65%13.52M | -97.51%351.71K | -88.22%2.07M | -85.53%2.96M | --2.96M | --8.47M | --14.11M | --17.55M | --20.45M |
| Free cash flow | -62.27%-9.15M | 47.74%-2.67M | 2.08%-5.25M | -21.53%-21.63M | ---5.51M | ---5.64M | ---5.12M | ---5.36M | ---17.79M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
